Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.

Xanthine oxidase inhibition (XOI) reduces oxidative stress in the vasculature. Moreover it reduces uric acid levels, a risk factor for the development of cardiovascular disease. As such, XOI holds a potentially dual mechanism for the treatment of cardiovascular disease.